FDA Orange Book · active-ingredient family
Probenecid
Probenecid is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:BENEMID · NDA 007898
1
Brand (NDA)
7
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| BENEMIDRLD | MERCK | NDA 007898 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (7)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PROBENECID | RISING | ANDA 217020 | AB | Nov 20, 2023 | |
| PROBENECID | IVAX SUB TEVA PHARMS | ANDA 083740 | — | May 09, 1984 | |
| PROBENECID | WATSON LABS TEVA | ANDA 084442 | AB | Mar 29, 1983 | |
| PROBENECID | WATSON LABS | ANDA 086150 | — | Apr 23, 1982 | |
| PROBALAN | LANNETT | ANDA 080966 | AB | Approved Prior to Jan 1, 1982 | |
| PROBENECID | AUROBINDO PHARMA USA | ANDA 084211 | — | Approved Prior to Jan 1, 1982 | |
| PROBENECID | LEDERLE | ANDA 086917 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Probenecid — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
